CN1074918C - 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用 - Google Patents

罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用 Download PDF

Info

Publication number
CN1074918C
CN1074918C CN94192664A CN94192664A CN1074918C CN 1074918 C CN1074918 C CN 1074918C CN 94192664 A CN94192664 A CN 94192664A CN 94192664 A CN94192664 A CN 94192664A CN 1074918 C CN1074918 C CN 1074918C
Authority
CN
China
Prior art keywords
ropivacaine
blockade
group
analgesia
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94192664A
Other languages
English (en)
Chinese (zh)
Other versions
CN1126435A (zh
Inventor
A·T·伊克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1074918(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Publication of CN1126435A publication Critical patent/CN1126435A/zh
Application granted granted Critical
Publication of CN1074918C publication Critical patent/CN1074918C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Air Conditioning Control Device (AREA)
  • Particle Accelerators (AREA)
CN94192664A 1993-06-28 1994-05-26 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用 Expired - Fee Related CN1074918C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
SE9302218-4 1993-06-28
SE93022184 1993-06-28

Publications (2)

Publication Number Publication Date
CN1126435A CN1126435A (zh) 1996-07-10
CN1074918C true CN1074918C (zh) 2001-11-21

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192664A Expired - Fee Related CN1074918C (zh) 1993-06-28 1994-05-26 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269A7 (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
JP2001510794A (ja) * 1997-07-21 2001-08-07 ダーウィン・ディスカバリー・リミテッド レボブピバカインとその使用
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP2209450A4 (en) * 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
US9668974B2 (en) 2012-05-10 2017-06-06 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANESTHESIA AND ANALGESIA,V01.70, 1990.1.1 M.CONCEPCION,MD等,"A NEW LOCAL ANESTHETIC ROPIVACAINE". *

Also Published As

Publication number Publication date
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
CN1126435A (zh) 1996-07-10
HUT75115A (en) 1997-04-28
IS4174A (is) 1994-12-29
WO1995000148A1 (en) 1995-01-05
NZ268110A (en) 1999-06-29
TW285640B (enExample) 1996-09-11
DK0706395T3 (da) 2002-07-22
DE706395T1 (de) 1997-09-04
NO955313L (no) 1995-12-27
ES2099048T3 (es) 2002-11-16
HK1010344A1 (en) 1999-06-17
FI956269A0 (fi) 1995-12-27
PL312198A1 (en) 1996-04-01
RU2152215C1 (ru) 2000-07-10
PL175518B1 (pl) 1999-01-29
NO955313D0 (no) 1995-12-27
IL110006A (en) 1999-01-26
GR970300013T1 (en) 1997-05-31
IL110006A0 (en) 1994-11-11
LV12918B (en) 2003-03-20
ATE216237T1 (de) 2002-05-15
CA2165446A1 (en) 1995-01-05
ES2099048T1 (es) 1997-05-16
AU692161B2 (en) 1998-06-04
EP0706395B1 (en) 2002-04-17
CZ283300B6 (cs) 1998-02-18
US5670524A (en) 1997-09-23
JPH09500620A (ja) 1997-01-21
CZ336495A3 (en) 1996-06-12
JP3725541B2 (ja) 2005-12-14
EE03205B1 (et) 1999-08-16
HU218949B (hu) 2001-01-29
DE69430427T2 (de) 2002-11-14
EP0706395A1 (en) 1996-04-17
US5834489A (en) 1998-11-10
PH31258A (en) 1998-06-18
HU9503692D0 (en) 1996-02-28
SK164695A3 (en) 1996-07-03
LT3449B (en) 1995-10-25
DE69430427D1 (de) 2002-05-23
SA94150010B1 (ar) 2006-04-04
AU7086694A (en) 1995-01-17
BR9406865A (pt) 1996-03-26
SK280111B6 (sk) 1999-08-06
PT706395E (pt) 2002-09-30
CA2165446C (en) 2005-07-05
FI956269A7 (fi) 1995-12-27
MY119360A (en) 2005-05-31
LTIP1958A (en) 1995-01-31
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
Doyle et al. Pre-emptive effect of multimodal analgesia in thoracic surgery
Saiah et al. Epidural-morphine-induced pruritus: propofol versus naloxone
KR100343314B1 (ko) 만성통증치료에유용한레보부피바카인
Smith et al. Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia
Niemi et al. Comparison of intrathecal fentanyl infusion with intrathecal morphine infusion or bolus for postoperative pain relief after hip arthroplasty
CN1074918C (zh) 罗哌卡因在具有最小运动神经阻断的止痛作用的药物制造中的应用
Fournier et al. Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total-hip replacement
CA2294950C (en) Levobupivacaine and its use
Murga et al. The effect of clonidine on intra‐operative requirements of fentanyl during combined epidural/general anaesthesia
Lee et al. Cauda equina syndrome after incidental total spinal anesthesia with 2% lidocaine
CA2230648A1 (en) Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd)
Milligan et al. The characteristics of analgesic requirements following subarachnoid diamorphine in patients undergoing total hip replacement
Stanton-Hicks et al. High thoracic epidural with sufentanil for post-thoracotomy pain
Domsky et al. Patient-controlled spinal analgesia for postoperative pain control
RU2367424C1 (ru) Способ обезболивания после хирургических операций из малоинвазивного доступа в абдоминальной хирургии
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Leicht et al. Prolongation of postoperative epidural sufentanil analgesia with epinephrine
Ahmad et al. COMPARATIVE EVALUATION OF CLONIDINE VERSUS TRAMADOL AS ADJUVANT TO EPIDURAL ANAESTHESIA WITH 0.5% BUPIVACAINE FOR LOWER LIMB ORTHOPEDIC PROCEDURES
RU2192895C2 (ru) Способ лечения отморожения нижних конечностей
Hari et al. A clinical comparison between intrathecal and intravenous infusion of magnesium sulphate as an adjuvant to hyperbaric 0.5% bupivacaine in spinal anaesthesia for elective infraumbilical surgeries
RU2056110C1 (ru) Способ лечения алкоголизма
Manzoor et al. ISSN-O: 2458-868X, ISSN–P: 2458-8687
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Jung et al. Combination of nefopam and remifentanil is more effective to reduce rocuronium-induced withdrawal response compared with remifentanil alone: a prospective, double-blinded, randomized control study
Malliwal Evaluation of Epidural Buprenorphine for Postoperative Analgesia for Below Umbilical Surgical Procedures

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20011121

Termination date: 20100526